Data from The Leukemia and Lymphoma Molecular Profiling Project that analyzed gene expression in 240 DLBCL patient samples demonstrated reduced surface expression of MHC and CD58 molecules in DLBCL, which inhibits T-cell and NK-cell infiltration [50,51]. This evidence concerns the gene HLA-C and diffuse large B-cell lymphoma.